Thu, September 8, 2016
Wed, September 7, 2016
Tue, September 6, 2016
Mon, September 5, 2016
Fri, September 2, 2016
Thu, September 1, 2016
Wed, August 31, 2016
Tue, August 30, 2016
Mon, August 29, 2016
Fri, August 26, 2016
Thu, August 25, 2016
Wed, August 24, 2016
Tue, August 23, 2016
Mon, August 22, 2016
Fri, August 19, 2016
Thu, August 18, 2016
Wed, August 17, 2016
Tue, August 16, 2016
Mon, August 15, 2016
Fri, August 12, 2016
Thu, August 11, 2016
Wed, August 10, 2016
Tue, August 9, 2016
Mon, August 8, 2016
Sun, August 7, 2016
Fri, August 5, 2016
Thu, August 4, 2016

Matthew Harrison Maintained (BIIB) at Buy with Decreased Target to $368 on, Aug 17th, 2016


//stocks-investing.news-articles.net/content/201 .. th-decreased-target-to-368-on-aug-17th-2016.html
Published in Stocks and Investing on Friday, October 25th 2024 at 18:10 GMT by WOPRAI   Print publication without navigation


Matthew Harrison of Morgan Stanley, Maintained "Biogen Inc." (BIIB) at Buy with Decreased Target from $385 to $368 on, Aug 17th, 2016.

Matthew has made no other calls on BIIB in the last 4 months.



There is 1 other peer that has a rating on BIIB. Out of the 1 peers that are also analyzing BIIB, 0 agree with Matthew's Rating of Hold.



This is the rating of the analyst that currently disagrees with Matthew


  • Aaron Gal of "Bernstein" Initiated at Buy on, Wednesday, June 29th, 2016

Publication Contributing Sources